{"id":"W3105684072","doi":"10.1136/ijgc-2020-igcs.3","title":"3 Postprogression efficacy outcomes from the phase 3 ARIEL3 study of rucaparib in patients with platinum-sensitive recurrent ovarian carcinoma associated with either BRCA1 or BRCA2 mutations","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ottawa Hospital","funders":"","keywords":"Internal medicine; Medicine; Oncology; Ovarian cancer; BRCA mutation; Placebo; Nausea; Clinical endpoint; Cancer; Clinical trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003308819,0.001083989,0.002295125,0.0004733193,0.0005386164,0.001476905,0.0009028944,0.001317902,0.00309375],"category_scores_gemma":[0.002149024,0.0003731503,0.004120586,0.0005013917,0.0006095544,0.001260018,0.0005788786,0.004086894,0.0008154362],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009140892,"about_ca_system_score_gemma":0.0009221258,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001647505,"about_ca_topic_score_gemma":0.004961188,"domain_scores_codex":[0.9991261,0.0003721069,0.00005264009,0.0001201327,0.0001031719,0.0002258968],"domain_scores_gemma":[0.9980232,0.0005457365,0.000463047,0.0001886405,0.0001411064,0.0006383482],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8229823,0.008485761,0.05200534,0.001026855,0.009812556,0.000356727,0.0002561611,0.004623773,0.007399126,0.0003563886,0.008090448,0.08460453],"study_design_scores_gemma":[0.3503952,0.250851,0.3640953,0.0002141881,0.01386609,0.0008216879,0.0002746327,0.004005693,0.003849953,0.00110848,0.0103314,0.0001863891],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9840464,0.005450639,0.0004085883,0.0007165028,0.0001267136,0.0005001504,0.005473257,0.00009985956,0.003178013],"genre_scores_gemma":[0.9852711,0.001215713,0.0004504135,0.001348944,0.0001610314,0.0004710775,0.00891191,0.00004085348,0.002128993],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003308819,"threshold_uncertainty_score":0.01749891,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05720377875601789,"score_gpt":0.3614086970169437,"score_spread":0.3042049182609258,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}